Juanfei Peng

511 citations
13 papers · 285 indexed · h-index 9
Topics
RNA modifications and cancer (6 papers)Cancer-related molecular mechanisms research (4 papers)Circular RNAs in diseases (3 papers)
Partner nations
ChinaUnited States

In The Last Decade

Juanfei Peng

13 papers receiving 284 citations

Peers

Juanfei Peng
Comparison fields: 5 of 45
  • Molecular Biology 218
  • Cancer Research 160
  • Oncology 58
  • Pulmonary and Respiratory Medicine 42
  • Physiology 27
Replace Feiye Liu with:
Feiye Liu China
Rujuan Bao China
Noan‐Minh Chau Singapore
Ifra Mushtaq India
Min Cheng China
Wenxin Wei China
Chengkai Jiang China
Shoumei Yang China
Juanfei Peng relative to Feiye Liu China Feiye Liu's profile →
Citations per field
00.5×2.7×
Feiye Liu · 1×
Citations per year

Countries citing papers authored by Juanfei Peng

Since Specialization
Citations

This map shows the geographic impact of Juanfei Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juanfei Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juanfei Peng more than expected).

Fields of papers citing papers by Juanfei Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juanfei Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juanfei Peng. The network helps show where Juanfei Peng may publish in the future.

Co-authorship network of co-authors of Juanfei Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Juanfei Peng. A scholar is included among the top collaborators of Juanfei Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juanfei Peng. Juanfei Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 5
2 5
3 18
4 15
5 12
6 54
7 28
8 26
9 48
10 50
11 4
12
[Proliferative and invasive effects of inhibitors of kinase 4(P15(ink4b) and P16(ink4a)/CDKN2) gene activation on RKO human colorectal cancer cells].
2
13
Oridonin-induced apoptosis in leukemia K562 cells and its mechanism.
18

About Juanfei Peng

Juanfei Peng is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 13 papers that have together received 285 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (4 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (160 citations), Molecular Biology (218 citations) and Oncology (58 citations). Juanfei Peng has collaborated with scholars based in China and United States. Frequent co-authors include Shineng Zhang, Fengting Huang, Yanyan Zhuang, Wen‐Ying Chen, Yuanhua Li, Zhe Zhu, Yeqing Liu, Herui Yao, Yanyan Zhuang and Haojie Huang. Their work appears in journals such as World Journal of Gastroenterology, Cell Death and Disease and Digestive Diseases and Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026